MSD Animal Health has introduced a transdermal pour-on solution it says is proven to reduce pyrexia (fever) associated with bovine respiratory disease (BRD).

The non-steroidal anti-inflammatory solution has been demonstrated to reduce fever as early as four hours after administration, due to the rapid absorption of active flunixin through the skin and into the bloodstream.

Transdermal application requires less handling, resulting in less stress on animals and leading to inherent health and wellness advantages.

It also offers the added benefit of needle-free administration, with no injection site lesions and a higher value end product.

Siddartha Torres, of MSD Animal Health, said: “This solution allows for a more convenient way to relieve animals from fever, and improve respiratory and depression scores associated with BRD.”

The procedure means there is no need for additional assistance, head gates or restraints commonly associated with injectable administration, which translates to reduced cost per treatment.

The solution is available in pre-calibrated packaging, ensuring the correct dose is given. The bottle is designed for proper application along the animal’s back and the red-coloured solution makes it simple to accurately and quickly measure the dose volume for each animal.

MSD Animal Health believes the solution will become an important part of health programmes where the reduction of fever associated with BRD is indicated.

Spokesman Martyn Phillips said: “The novel application simplifies a usually time-consuming and strenuous process, making it easier for both the animals and the people who care for them.”

View your activity >

Leave a Reply

Be the First to Comment!

Notify of